Introduction {#s1}
============

Efficient clearance of neurotransmitters from the synaptic cleft is crucial for terminating a synaptic signal. These cleared neurotransmitters must then be recycled for sustained synaptic transmission (i.e., to maintain stable levels of transmitters) ([@bib2]). Neurons that utilize histamine as a neurotransmitter play important roles in a variety of biological processes, including cognition, sleep, and metabolism, and dysfunction of the histaminergic system in the brain has been linked to multiple neurological diseases ([@bib13]; [@bib24]). Histamine is particularly important in the *Drosophila* visual system ([@bib15]), and histamine recycling is the dominant pathway for maintaining adequate levels of histamine in adult photoreceptors ([@bib3]). In this system, and in mammalian systems as well, the histamine recycling process involves both neurons and glial cells that surround the synapse ([@bib11]; [@bib41]). In fact, a network of glia cells and pigment cells interconnected via gap junctions plays a key role in the long-distance recycling of histamine in the *Drosophila* visual system ([@bib7]). However, the mechanisms by which this cellular network recycles histamine and its metabolites are unknown.

Once histamine is released by a photoreceptor into the optic lamina, it is quickly removed from the synaptic cleft by epithelia glial cells that surround the synapse. In these laminar glia, histamine is conjugated to β-alanine by an N-β-alanyl-dopamine synthase, called Ebony, to form the inactive metabolite, carcinine ([@bib3]; [@bib30], [@bib29]). Recently, a carcinine transporter, CarT that is responsible for the uptake of carcinine from the synaptic cleft into photoreceptors has been identified ([@bib8]; [@bib31]; [@bib39]). The discovery that CarT retrieves carcinine directly from the laminar synaptic cleft indicates that carcinine is not transported from laminar glia to photoreceptor cell bodies through a long-distance trafficking mechanism involving the laminar glial and pigment cell network.

Within photoreceptors, carcinine is hydrolyzed to generate histamine and β-alanine, a reaction catalyzed by an N-β-alanyl-dopamine hydrolase called Tan ([@bib3]; [@bib34]). This regenerated histamine is then repackaged into synaptic vesicles for subsequent light-induced release, but it is unclear how β-alanine is returned to the laminar glial cells (where it is needed to inactivate histamine). It is also unclear whether β-alanine recycling is required for visual transmission. The finding that high levels of β-alanine are detected in retinal pigment cells suggested that pigment cells may be critical for the transport and storage of β-alanine in this system ([@bib5]; [@bib7]). To address these questions, we sought to determine whether there was a β-alanine transporter that was required for *Drosophila* vision transmission.

Here, we identified BalaT, which is a plasma membrane transporter capable to transporting β-alanine into cells. Mutations in the *balat* gene disrupted photoreceptor synaptic transmission, phototaxis behaviors, and contents and retinal distribution of β-alanine. BalaT expression in retinal pigment cells completely rescued the defective visual transmission of *balat* mutants. Furthermore, the gap junction proteins Inx1 and Inx3 were required in retinal pigment cells for visual neurotransmission. We therefore provide evidence for a novel β-alanine recycling pathway, in which β-alanine that is released from photoreceptor cells is taken up and stored by retinal pigment cells, and then delivered to laminar glia via gap junctions, where histamine is inactivated by conjugation with β-alanine.

Results {#s2}
=======

CG3790 transports β-alanine in vitro {#s2-1}
------------------------------------

In *Drosophila* photoreceptors, carcinine is hydrolyzed to form histamine and β-alanine ([@bib34]; [@bib35]). Histamine is then released as a neurotransmitter, taken up by laminar glial cells, and then conjugated with β-alanine to form carcinine. Although it is known that CarT transports carcinine into photoreceptors, it is unclear how β-alanine is delivered to laminar glia. To begin to understand this process, we sought to identify a β-alanine transporter in the fly visual system. We speculated that a transporter responsible for β-alanine uptake would likely be enriched in fly heads, so we examined previous RNA-seq data comparing mRNAs isolated from the head with mRNAs isolated from the body ([@bib40]). Among \~600 putative transmembrane transporters encoded by the *Drosophila* genome, we identified 20 head-enriched genes ([Table 1](#tbl1){ref-type="table"}) that represented potential β-alanine transporters ([Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.29146.003Figure 1.CG3790 is a retina-enriched β-alanine transporter.(**A**) Screening for a β-alanine transporter. HEK293T cells transiently expressing one of \~20 head-enriched potential transporters were exposed to \[^3^H\]-β-alanine, which was added to the ECF buffer (final concentration 3.7 × 10^4^ Bq). RFP (red fluorescent protein) was expressed as a negative control. (**B**) CG3790 transported β-alanine into S2 cells. Mouse GAT3 and RFP were used as positive and negative control, respectively. The results given are the mean values ± S.D. of four experiments. (**C--D**) CG3790 was expressed at high levels in the compound eye. (**C**) Relative RNA transcript levels (RT-PCR experiments) show that CG3790 expression is enriched in wild-type (*w^1118^*) heads compared with wild-type bodies or *GMR-hid* heads. (**D**) Relative *CG3790* transcript levels from wild-type (wt) bodies, wt heads, and *GMR-hid* heads (*gpdh* served as an internal control). RNA levels were normalized to levels in wt bodies, which were set to 1. Error bars indicate standard deviations (SDs) from three replicate experiments. Significant differences between candidates and control were determined using unpaired t-tests (\*\*p\<0.01; ns, not significant). (**E**) S2 cells were transiently transfected with 3xFlag-tagged CG3790, and then labeled with Flag antibody (green) and DAPI (blue). Scale bar, 2 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.003](10.7554/eLife.29146.003)10.7554/eLife.29146.004Figure 1---source data 1.Relates to [Figure 1A and B](#fig1){ref-type="fig"}.\[^3^H\]-β-alanine uptake data for screening for β-alanine transporter in HEK 293 T cells and S2 cells (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.004](10.7554/eLife.29146.004)10.7554/eLife.29146.005Figure 1---source data 2.Relates to [Figure 1D](#fig1){ref-type="fig"}.Relative *CG3790* transcript levels from wild-type (wt) bodies, wt heads, and GMR-hid heads. RNA levels were normalized to levels in wt bodies, which were set to 1 (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.005](10.7554/eLife.29146.005)10.7554/eLife.29146.006Figure 1---figure supplement 1.CG3790 is a SLC22 family protein.Alignment of the *Drosophila* CG3790 amino acid sequence with mouse OCT3 (mOCT3) and human OCT3 (hOCT3). Identical residues, found in at least two proteins, are enclosed in green boxes. CG3790 is 29% identical to mOCT3% and 30% identical to hOCT3. The transmembrane domains are indicated by solid lines above the sequences. The running tally of amino acids is indicated to the right.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.006](10.7554/eLife.29146.006)10.7554/eLife.29146.007Figure 1---figure supplement 2.CG3790 is unable to transport histamine and GABA.(**A**) CG3790 did not transport GABA into S2 cells. Mouse GAT3 was used as a positive control, and RFP was used as a negative control. (**B**) CG3790 did not exhibit histamine transporting activity in S2 cells. Human OCT2 and RFP were used as positive and negative control, respectively. \[^3^H\]-GABA or \[^3^H\]-histamine was added to the ECF buffer (final concentration 3.7 × 10^4^ Bq). The results given are the mean values ± S.D. of three experiments. Significant differences were determined using unpaired t-tests (\*\*\*p\<0.001; ns, not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.007](10.7554/eLife.29146.007)10.7554/eLife.29146.008Figure 1---figure supplement 2---source data 1.Relates to [Figure 1---figure supplement 2A and B](#fig1s2){ref-type="fig"}.\[^3^H\]-histamine uptake data in S2 cells transfected mock and RFP negative control or mGAT3. \[^3^H\]-GABA uptake data in S2 cells transfected mock and RFP negative control or hOCT2 (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.008](10.7554/eLife.29146.008)10.7554/eLife.29146.009Figure 1---figure supplement 3.*GMR-hid* abolished expression of *ninaE* and *pdh*.(**A--B**) Wild-type heads contain more transcripts for (**A**) *ninaE* and (**B**) *pdh* than wild-type bodies and *GMR-hid* heads (*gpdh* served as an internal control, and mRNA levels were normalized to wild-type body). Data is processed by logarithmic 2 and averaged from three replicate experiments. Error bars indicate SDs. Significant differences between candidates and control were determined using unpaired t-tests (\*\*\*p\<0.001).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.009](10.7554/eLife.29146.009)10.7554/eLife.29146.010Figure 1---figure supplement 3---source data 1.Relates to [Figure 1---figure supplement 3A and B](#fig1s3){ref-type="fig"}.Relative *ninaE* and *pdh* transcript levels from wild-type (wt) bodies, wt heads, and GMR-hid heads. RNA levels were normalized to levels in wt bodies. Data is processed by logarithmic 2 (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.010](10.7554/eLife.29146.010)10.7554/eLife.29146.011Table 1.Description of 20 head-enriched genes.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.011](10.7554/eLife.29146.011)CG numberNameDescription CG3790\
Organic anion transmembrane transporter activity CG18660Nckx30CSodium/potassium/calcium exchanger CG2893zydecoPotassium-dependent sodium/calcium exchanger CG7342\
Organic anion transmembrane transporter activity CG13610Orct2Organic cation transporter CG6331OrctOrganic anion transmembrane transporter activity CG6126\
Organic anion transmembrane transporter activity CG4360\
Nucleic acid binding CG3159Eaat2L-aspartate transmembrane transporter activity CG6723\
Sodium/solute symporter CG11010Ent3Nucleoside transmembrane transporter activity CG13743\
Amino acid transporter CG10804\
Neurotransmitter transporter activity CG4545SerTMonoamine transmembrane transporter activity CG5281\
EamA domain CG43066\
Neurotransmitter transporter activity CG7442SLC22ACholine transmembrane transporter activity CG7708\
Sodium/solute symporter CG13248\
Amino acid/polyamine transporter I CG42322\
Solute carrier family 35 member F3/F4

To determine if any of these candidate transporters could transport β-alanine, we used HEK293T cells to perform uptake assays. Each candidate was transiently expressed in HEK293T cell, and their ability to uptake \[^3^H\]-β-alanine was assessed. Only one candidate transporters, CG3790, exhibited β-alanine uptake activity ([Figure 1A](#fig1){ref-type="fig"}). The β-alanine content of CG3790-transfected cells was approximately 119 Bq/mg, which was 2.7-fold greater than measured for mock- or RFP-transfected controls (55 and 53 Bq/mg, respectively). CG3790 shares significant amino acid identity with the mammalian solute carrier family 22 (SLC22), which includes both mouse and human OCT3 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The β-alanine transporting activity of CG3790 was further confirmed in S2 cells ([Figure 1B](#fig1){ref-type="fig"}). Mouse GAT3 (GABA transporter type 3), which is known to efficiently take up β-alanine, exhibited levels of β-alanine transporting activity that were similar to CG3790, suggesting that CG3790 is a *bona fide* β-alanine transporter ([@bib9]) ([Figure 1B](#fig1){ref-type="fig"}). We next sought to determine whether CG3790 is a specific β-alanine transporter in *Drosophila*. Because a histamine transporter has not yet been identified, we first asked whether CG3790 is able to transport histamine. Histamine uptake assays revealed that CG3790 does not exhibit histamine uptake activity. As a control, the human Organic Cation Transporter (OCT2), which is known to take up histamine, exhibited high levels of histamine transport activity when expressed in S2 cells ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Since mGAT3 is also a GABA transporter, we asked whether CG3790 is able to transport GABA. While mGAT3 efficiently transported GABA, CG3790 did not exhibit GABA transporting activity when expressed in S2 cells ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Moreover, when we expressed Flag-tagged CG3790 in S2 cells the Flag signal localized exclusively to the plasma membrane ([Figure 1E](#fig1){ref-type="fig"}). These data suggest that *CG3790* encodes a plasma membrane β-alanine transporter.

To further confirm that the CG3790 transporter functions in the fly head, we performed quantitative PCR comparing mRNAs isolated from wild-type heads, wild-type bodies, or heads from *GMR-hid* flies, which are devoid of eyes. As is seen with other eye-specific genes including *ninaE* (*neither inactivation nor afterpotential E*), which is expressed exclusively in photoreceptor cells ([@bib23]), and *pdh* (*pigment-cell-enriched dehydrogenase*), which is expressed exclusively in retinal pigment cells) ([@bib37]), *CG3790* mRNA transcripts were absent from fly bodies ([Figure 1C--D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 3A--B](#fig1s3){ref-type="fig"}). Ectopic expression of the pre-apoptotic gene *hid* via the *glass multiple reporter* (*GMR*) promoter results in eye ablation ([@bib12]; [@bib16]). As such, *ninaE* and *pdh* expression is greatly reduced in the heads of *GMR-hid* flies. Similarly, *CG3790* transcript levels were also greatly reduced in the heads of *GMR-hid* flies, suggesting that *CG3790* is primarily expressed in the fly compound eye ([Figure 1C--D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}). These findings indicate that *CG3790* encodes a retina-enriched plasma membrane β-alanine transporter. We therefore named this gene *balat* ([b]{.ul}eta-[ala]{.ul}nine [t]{.ul}ransporter).

BalaT is required for visual synaptic transmission {#s2-2}
--------------------------------------------------

To study the function of BalaT in visual perception, we generated two null mutations in the *balat* gene by deleting \~900 bp and \~660 bp genomic fragments using the CRISPR-associated single-guide RNA system (Cas9) ([Figure 2A](#fig2){ref-type="fig"}). PCR amplification of the *balat* locus from genomic DNA isolated from wild-type, *balat^1^,* and *balat^2^* flies revealed a truncated *balat* locus in the mutant samples. Thus, the *balat* locus is disrupted in *balat^1^* and *balat^2^* flies ([Figure 2B](#fig2){ref-type="fig"}).10.7554/eLife.29146.012Figure 2.Mutations in *balat* disrupt photoreceptor cell synaptic transmission and visual behavior.(**A**) Schematic for *balat* knock-out by sgRNA targeting. The organization of the *balat* locus and the expected structures of *balta^1^* and *balat^2^* alleles are shown. Boxes represent exons with the coding region between ATG and TAG. The sgRNA1 and sgRNA2 primer pair was used to generate the *balat^1^* allele; the sgRNA2 and sgRNA3 primer pair was used to generate the *balat^2^* allele. Arrows indicate the primers used for genomic PCR. (**B**) PCR products obtained from *balat^1^* and *balat^2^* mutants show successful gene deletions. (**C**) ERG recordings from: wild-type (*w^1118^*), *balat^1^*, *balat^2^*, *balat^1^;GMR-balaT*, *balat^1^;pdh-balaT, balat^2^;ninaE-balaT* and *w^+^; balat^1^* flies. Young flies (\<3 days after eclosion) were dark adapted for 1 min and subsequently exposed to a 5 s pulse of orange light. ON and OFF transients are indicated by arrows. All flies contained the *w^1118^* mutation except for the *w^+^; balat^1^* flies. (**D**) Quantitative analysis of the amplitudes of ERG OFF transients shown in C. (**E**) Phototaxis behaviors of wt, *balat^1^ balat^1^;GMR-balaT*, *balat^1^;pdh-balaT* and *balat^2^;ninaE-balaT* flies. Significant differences between mutant and wild-type flies were determined using unpaired t-tests (\*\*\*p\<0.001; ns, not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.012](10.7554/eLife.29146.012)10.7554/eLife.29146.013Figure 2---source data 1.Relates to [Figure 2D and E](#fig2){ref-type="fig"}.Quantitative analysis of the amplitudes of ERG OFF transients about wild-type (*w^1118^*), *balat^1^*, *balat^2^*, *balat^1^;GMR-balaT*, *balat^1^;pdh-balaT, balat^2^;ninaE-balaT* and *w^+^; balat^1^* flies. Quantitative of phototaxis behaviors of wt, balat1 balat1;GMR-balaT, balat1;pdh-balaT and balat2;ninaE-balaT flies (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.013](10.7554/eLife.29146.013)10.7554/eLife.29146.014Figure 2---figure supplement 1.Quantification of the ERG ON transients.Percentage of flies of indicated genotypes that have ON transients were quantified. The ERG profiles from at least 7 flies of each genotype were scored.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.014](10.7554/eLife.29146.014)

These *balat* mutations did not cause lethality or other visible phenotypes, so we performed electroretinogram (ERG) recordings to determine whether BalaT functions in phototransduction. Exposing wild-type flies to light results in two primary components in the ERG recording, including a sustained corneal negative response resulting from photoreceptor depolarization, and 'on' and 'off' transients resulting from postsynaptic neuronal activity in the optic lamina (downstream of the photoreceptors) ([@bib36]) ([Figure 2C](#fig2){ref-type="fig"}). Mutations in genes that disrupt histamine recycling exhibit reduced 'on' and 'off' transients, reflecting defective synaptic transmission of photoreceptors ([@bib39]). Similarly, both *balat^1^ and balat^2^* mutant flies lacked ERG 'on' and 'off' transients, indicating that BalaT is required for visual synaptic transmission ([Figure 2C and D](#fig2){ref-type="fig"}, and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To confirm that the loss of ERG transients resulted from mutation of the *balat* locus, we generated a *GMR-balat* transgenic fly, which expresses BalaT in the compound eyes under control of the *GMR* promoter. The *GMR-balat* transgene completely rescued the 'on' and 'off' transients when crossed into the *balat^1^* mutant flies ([Figure 2C](#fig2){ref-type="fig"}). Mutations in the *white* gene, which encodes an ATP-binding cassette (ABC) transporter, has been reported to affect histamine levels ([@bib4]). To make sure that the *white* mutation was not affecting ERG phenotypes exhibited by *balat* mutants, we crossed the *balat* mutation into a wild-type *white (w^+^*) background and found that 'on' and 'off' transients were still absent in this *w^+^; balat^1^* fly ([Figure 2C and D](#fig2){ref-type="fig"}).

Disrupting visual transmission results in blindness, which is reflected in the loss of phototaxis behavior ([@bib1]). We next used this behavioral assay to assess the ability of *balat* mutant flies to see. Consistent with the loss of 'on' and 'off' transients, *balat* mutant flies exhibited impaired phototaxis, which was fully restored by the *GMR-balat* transgene ([Figure 2E](#fig2){ref-type="fig"}). These results strongly support the conclusion that BalaT is involved in visual transmission and that the loss of BalaT severely disrupts vision.

BalaT localizes to pigment cells {#s2-3}
--------------------------------

It is not currently known how β-alanine is transported out of the photoreceptor cells once generated (along with histamine) by the Tan hydrolase. Having established that BalaT functions as a β-alanine transporter in the retina, we next sought to determine which cells express *balat*, with the goal of determining the site of β-alanine transport during phototransduction. As we were unable to generate a high affinity antibody against BalaT, we used CRISPR/Cas9-based genome editing to introduce mCherry into the *balat* locus, downstream of the native *balat* promoter (*balat-mcherry*) ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). We identified *balat-mcherry* flies though PCR and RFP immunofluorescence ([Figure 3---figure supplement 1B--C](#fig3s1){ref-type="fig"}). Importantly, homozygous *balat-mcherry* flies displayed the loss of 'on' and 'off' transients, as expected, indicating the insertion of *mcherry* into the *balat* locus ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}).

Photoreceptor cells and retinal pigment cells are the two major cell types in the compound eye. Staining with phalloidin and PDH labels the rhabdomere regions of photoreceptor cells and the retinal pigment cells, respectively. The mCherry signals in the *balat-mcherry* retina were predominantly detected in retinal pigment cells, as it overlapped with the PDH signal ([Figure 3A and B](#fig3){ref-type="fig"}). No mCherry signaling was detected in wild-type flies ([Figure 3C and D](#fig3){ref-type="fig"}).10.7554/eLife.29146.015Figure 3.BalaT localizes to pigment cells.(**A--B**) Compound eyes from *balat-mcherry* flies that express mCherry (red) driven by the endogenous *balat* promoter were labeled for PDH (green), mCherry (red), and phalloidin (blue). High-magnification images are shown in (**B**). (**C--D**) mCherry signals were not detected in wild-type (wt) retinas. Scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.015](10.7554/eLife.29146.015)10.7554/eLife.29146.016Figure 3---figure supplement 1.Generation of *balat-mcherry* flies.(**A**) Schematics for generating *balat-mcherry* flies. The mcherry fluorescent protein, driven by an eye-specific 3XP3 promoter, was inserted into the *balat* genomic locus using CRISPR/Cas9-mediated homologous recombination. The 3XP3 promoter region was subsequently removed by Cre recombinase. PCR primers (arrows, pF and pR) were used to verify the *balat-mcherry* knock-in flies. (**B**) Images show flies with the 3XP3-mcherry reporter inserted into the *balat* locus (*balat-3XP3-mcherry*), and the *balat-mcherry* knock-in flies after Cre/LoxP-mediated recombination. Scale bar represents 150 µm. (**C**) Genomic PCR products from wild-type (*w^1118^*), attP2, *balat-3XP3-mcherry*, and *balat-mcherry* flies show successful gene targeting. (**D**) ERG recordings from wild-type (*w^1118^*), *attP2*, *balat-3XP3-mcherry,* and *balat-mcherry* flies. The *mcherry* insertion caused the loss of 'on' and 'off' transients.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.016](10.7554/eLife.29146.016)

Since BalaT localized to retinal pigment cells, we next asked whether BalaT is required in pigment cells by performing tissue-specific rescue experiments. We expressed BalaT specifically in photoreceptor cells using the *ninaE* promoter (*ninaE-balat*) or in retinal pigment cells using the *pdh* promoter (*pdh-balat*). The *pdh-balat* transgene fully restored 'on' and 'off' transients and phototaxic behaviors when crossed into *balat^1^* mutant flies, whereas expressing BalaT in photoreceptor cells failed to rescue these phenotypes ([Figure 2C--E](#fig2){ref-type="fig"}, and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These results indicate that BalaT functions in pigment cells, and that pigment cells may play an important role in transporting β-alanine from photoreceptors to epithelia glial cells in the optic lamina.

Inx1 and Inx3 are required for visual synaptic transmission {#s2-4}
-----------------------------------------------------------

If β-alanine is transported into pigment cell by BalaT, it must then be transported from the pigment cells to the laminar glial cells, where it can be conjugated with histamine to form carcinine. It has recently been reported that a multicellular network involving laminar glia and pigment cells mediates long-distance recycling of histamine metabolites ([@bib7]). Since this transport relies on the gap junction protein Innexin 2 (Inx2) in glia, it is possible that gap junctions between pigment cells and laminar glial cells are important for β-alanine recycling, and thus for maintaining visual synaptic transmission. We first asked whether disruption of Inx2 in the retina affects fly visual transmission. Knocking down Inx2 in the retina (*inx2^RNAi^: GMR-gal4/UAS-inx2^RNAi^*) did not affect ERG transients ([Figure 4A and C](#fig4){ref-type="fig"}). However, there are seven Innexins, and Inx1, Inx2, and Inx3 are all expressed in the adult head. Knockdown of Inx1 or Inx3 in the compound eye also did not disrupt the ERG 'on' and 'off' transients ([Figure 4B and D](#fig4){ref-type="fig"}). Because these Innexins may have redundant functions, we knocked down combinations of two retinal Innexins and measured the effect on fly visual transmission. Knockdown of Inx1/Inx2 or Inx2/Inx3 did not affect ERG transients, but 'on' and 'off' transients were largely reduce by Inx1/Inx3 double knockdown ([Figure 4E--4G](#fig4){ref-type="fig"}). These results indicated that the gap junction proteins Inx1 and Inx3 are required in compound eyes for visual transmission.10.7554/eLife.29146.017Figure 4.Specific knockdown of Inx1 and Inx3 in compound eyes blocks visual neurotransduction.ERG recordings of (**A**) control (*GMR-gal4*), (**B**) *inx1^RNAi^* (*GMR-gal4/ UAS-inx1^RNAi^*), (**C**) *inx2^RNAi^* (*GMR-gal4/UAS-inx2^RNAi^*), (**D**) *inx3^RNAi^* (*GMR-gal4/ UAS-inx3^RNAi^*), (**E**) *inx1^RNAi^* + *inx2^RNAi^* (*GMR-gal4/UAS-inx1^RNAi^ UAS-inx1^RNAi^*), (**F**) *inx2^RNAi^* + *inx3^RNAi^* (*GMR-gal4/UAS-inx2^RNAi^ UAS-inx3^RNAi^*), and (**G**) *inx1^RNAi^* + *inx3^RNAi^* (*GMR-gal4/UAS-inx1^RNAi^ UAS-inx3^RNAi^*) are shown. Arrows indicate ON and OFF transients in (**A**). Flies (\~1 day after eclosion) were dark adapted for 1 min and subsequently exposed to a 5 s pulse of orange light. (**H--I**) β-alanine was immunolabeled in horizontal sections of heads from (**H**) control: *CG2198^RNAi^* (*GMR-gal4/UAS- CG2198^RNAi^*) and (**I**) *inx1^RNAi^* + *inx3^RNAi^* (*GMR-gal4/UAS-inx1^RNAi^ UAS-inx3^RNAi^*) flies. Re, retina; La, lamina; Me, medulla; Lo, lobula. (**J**) Fluorescence intensity ratios of β-alanine signals between retina and lobula. Quantifications of all genotypes are averages of six replicate experiments. Significant differences between *inx1^RNAi^* + *inx3^RNAi^* and controls (*CG2198^RNAi^* and *CG9962^RNAi^*) were determined using unpaired t-tests (\*\*\*p\<0.001; ns: not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.017](10.7554/eLife.29146.017)10.7554/eLife.29146.018Figure 4---source data 1.Relates to [Figure 4J](#fig4){ref-type="fig"}.Quantitative of fluorescence intensity ratios of β-alanine signals between retina and lobula of *inx1^RNAi^* + *inx3^RNAi^* and controls (*CG2198^RNAi^* and *CG9962^RNAi^*) (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.018](10.7554/eLife.29146.018)10.7554/eLife.29146.019Figure 4---figure supplement 1.Accumulation of β-alanine in heads of *Inx1* and *Inx3* double RNAi flies.Levels of β-alanine in heads of control and *inx1^RNAi^* + *inx3^RNAi^* (*GMR-gal4/UAS-inx1^RNAi^ UAS-inx3^RNAi^*) flies. Error bars indicate SDs, and significant differences between mutant and wt flies were determined using unpaired t-tests (\*\*\*p\<0.001).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.019](10.7554/eLife.29146.019)10.7554/eLife.29146.020Figure 4---figure supplement 1---source data 1.Relates to [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.Quantitative of levels of β-alanine in heads of control and *inx1^RNAi^* + *inx3^RNAi^* (*GMR-gal4/UAS-inx1^RNAi^ UAS-inx3^RNAi^*) flies (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.020](10.7554/eLife.29146.020)

β-alanine levels and distributions are altered in *balat* mutant flies {#s2-5}
----------------------------------------------------------------------

We next examined the in vivo levels of β-alanine, histamine, and carcinine in the heads of *balat* mutant flies via liquid chromatography-mass spectrometry (LC-MS). For *cart^1^* mutant flies, which cannot transport carcinine into photoreceptor cells, levels of histamine and β-alanine were significantly reduced ([Figure 5A and B](#fig5){ref-type="fig"}), as has been reported ([@bib39]). Similarly, levels of β-alanine and histamine were significantly reduced in *balat^1^* mutant flies ([Figure 5A and B](#fig5){ref-type="fig"}). Reduction of histamine in *balat^1^* mutant flies indicates defective histamine recycling and explains the disruption of photoreceptor synaptic transmission in *balat^1^* mutants. Reductions in β-alanine may result from inadequate β-alanine storage and/or transport into pigment cells ([@bib5]). These results therefore support the hypothesis that BalaT transports β-alanine into retinal pigment cells.10.7554/eLife.29146.021Figure 5.Loss of BalaT affects the level and distribution of β-alanine in vivo.(**A--B**) Levels of (**A**) β-alanine and (**B**) histamine in heads of wild-type (wt, *w^1118^*), *cart^1^*, and *balat^1^* flies are shown. Error bars indicate SDs, and significant differences between mutant and wt flies were determined using unpaired t-tests (\*p\<0.05; \*\*p\<0.01). (**C--E**) β-alanine was immunolabeled in horizontal sections of heads from (**C**) wild-type (*w^1118^*), (**D**) *balat^1^*, and (**E**) *balat^1^;GMR-balat* flies. Re, retina; La, lamina; Me, medulla; Lo, lobula. (**F**) Fluorescence intensity ratios of β-alanine labeling between retina and lobula. Significant differences between mutant and wild-type flies were determined using unpaired t-tests (\*\*p\<0.01; ns: not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.021](10.7554/eLife.29146.021)10.7554/eLife.29146.022Figure 5---source data 1.Relates to [Figure 5A and B](#fig5){ref-type="fig"}.Quantitative of levels of β-alanine and histamine in heads of wild-type, *cart^1^*, and *balat^1^* flies (.xlsx file).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.022](10.7554/eLife.29146.022)10.7554/eLife.29146.023Figure 5---figure supplement 1.Distribution of β-alanine was unaffected in *pyd1* and *balck* double mutant flies.β-alanine was immunolabeled in horizontal sections of heads from (**A**) wild type (*w^1118^*) and (**B**) *pyd1;b^1^* flies. Re, retina; La, lamina; Me, medulla; Lo, lobula. (**C**) Fluorescence intensity ratios of β-alanine signals between retina and lobula. Quantifications of both genotypes are averages of six replicate experiments. Significant difference between wild type and *pyd1;b^1^* was determined using unpaired t-tests (ns: not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.29146.023](10.7554/eLife.29146.023)

If flies are not able to transport β-alanine into pigment cells for storage, β-alanine should be specifically decreased in the retina. To test this idea, we sectioned fly heads and labeled them with an antibody against β-alanine. In wild-type flies, levels of β-alanine were highest in the retina, consistent with previous analyses ([@bib5]; [@bib7]) ([Figure 5C and F](#fig5){ref-type="fig"}). In contrast, levels of β-alanine were lower in *balat^1^* sections (for comparison, retinal signals were normalized to the β-alanine signal in the lobula) ([Figure 5D and F](#fig5){ref-type="fig"}). *GMR-balat* restored retinal β-alanine levels in *balat^1^* mutants ([Figure 5E and F](#fig5){ref-type="fig"}), and rescued photoreceptor synaptic transmission. Reduced levels of β-alanine in retina lacking BalaT support the hypothesis that BalaT transports β-alanine into retinal pigment cells. We next checked if reductions in β-alanine change its distribution. In *pyd1* and *black* double mutants (*pyd1;b^1^*), two independent metabolic pathways for de novo β-alanine biosynthesis are blocked and thus β-alanine levels are largely reduced ([@bib5]). However, in *pyd1;b^1^* flies the pattern of β-alanine distribution is the same as seen in wild type, although immune intensity is reduced, as is the case with *balat^1^* mutant flies ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Therefore, pigment cells may serve as a reservoir of storedβ-alanine through a BalaT-dependent mechanism. Since Inx1/Inx3 double knockdown flies showed significant reductions in 'on' and 'off' transients, we asked whether Inx1/Inx3 is required for β-alanine trafficking. Of importance, β-alanine primarily accumulated in the retinal layer of Inx1/Inx3 double knock-down flies compared with control flies with either *CG2198* or *CG9962* RNAi ([Figure 4H--J](#fig4){ref-type="fig"}). Meanwhile in vivo levels of β-alanine in heads of Inx1/Inx3 double knockdown flies are significantly higher than in control flies ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results further support our hypothesis that Inx1/Inx3 functions to transport β-alanine back into glia cell. Taken together, we have identified a previously uncharacterized β-alanine transporter, which we have named BalaT, and shown that BalaT is responsible for β-alanine transportation and storage in pigment cells.

Discussion {#s3}
==========

Histamine is the primary neurotransmitter released by photoreceptors in flies, and the synthesis of histamine can occur de novo by photoreceptor cell-specific histidine decarboxylase ([@bib6]; [@bib14]). However, during light stimulation, flies depend primarily on histamine recycling to sustain tonic visual transmission. Histamine is inactivated when Ebony catalyzes its conjugation to β-alanine in laminar glial cells ([@bib3]; [@bib29]). In photoreceptors, CarT and Tan are involved in transporting carcinine and regenerating histamine, respectively ([@bib8]; [@bib31]; [@bib35]; [@bib39]). Histamine is then loaded into synaptic vesicles, but fate of the β-alanine generated by Tan remains unknown. Here, we identify a new β-alanine transporter, BalaT, and provide evidence that BalaT is required for visual transmission. BalaT is a plasma membrane protein, and is sufficient to facilitate β-alanine uptake in cultured cells. BalaT is expressed predominantly by retinal pigment cells, and the specific expression of BalaT in these cells rescues photoreceptor synaptic transmission in *balat^1^* mutant flies. The reduced levels and altered distribution of β-alanine in the heads of *balat^1^* mutants support the hypothesis that BalaT functions to transport β-alanine. Therefore, we suggest that a novel β-alanine transporter, BalaT, functions in retinal pigment cells to help recycle β-alanine.

Disrupting the synthesis of histamine and carcinine abolishes photoreceptor synaptic transmission ([@bib3]; [@bib6]). The transport of β-alanine seems less important, as it is present at higher concentrations in Drosophila. Two common metabolic pathways have been shown to synthesize β-alanine: (1) aspartate decarboxylase, encoded by the *black* gene ([@bib17]; [@bib26]), and (2) the uracil degradation pathway, which includes the enzymes dihydropyrimidine dehydrogenase (Pyd1), dihydropyrimidine amidohydrolase (Pyd2), and β-ureidopropionase (Pyd3) ([@bib27]; [@bib28]). The Black protein is enriched in lamina glia, together with the protein Ebony, and functions as the major enzyme in generating β-alanine ([@bib42]). Although levels of β-alanine are reduced in the heads of *black* mutants (or *pyd1 and black* double mutants) compared to wild type, these flies still exhibit ERG transients ([@bib5]; [@bib42]). Therefore, an efficient β-alanine recycling systems has been proposed to compensate for the rapid loss of β-alanine that occurs in the conversion of histamine to carcinine ([@bib5]). Here we show that mutations in *balat* disrupted transport and storage of β-alanine in the retina, resulting in dramatically reduced photoreceptor synaptic activity and visual behavior. Thus, we propose that Balat plays a key role in shuttling β-alanine from photoreceptor cells to glial cells.

A similar recycling system has been demonstrated for histamine. Mutations in *Hdc* (histidine decarboxylase) result in the loss of visual transduction. Feeding these flies histamine fully restores the visual transduction, whereas supplying histamine fails to rescue the ERG phenotypes of *ebony* mutants or *Hdc;ebony* double mutant flies ([@bib21], [@bib22]; [@bib42]). In *pyd1;black* double mutant*s*, β\--alanine levels are still higher than histamine, which may be because of the uptake of exogenous β-alanine ([@bib5]). Meanwhile, the β-alanine recycling pathway is able to sustain visual synaptic transmission in *black* mutant flies, even in the absence of in situ β-alanine generation. Therefore, β-alanine recycling is essential for maintaining histamine homeostasis and photoreceptor synaptic transmission. In addition, establishing and maintaining a β-alanine pool play key roles in sustaining visual synaptic transmission.

The majority of pigment granules, which reduce the intensity of light exposure, are formed in retinal pigment cells of the *Drosophila* compound eye. Recently, it has been demonstrated that retinal pigment cells are functionally equivalent to cells within the mammalian retinal pigment epithelium (RPE), in terms of chromophore cycling ([@bib33]; [@bib37], [@bib38]). Just like chromophore (a subunit of rhodopsin) is sent back to pigment cells for regeneration, it has been suggested that the metabolism of β-alanine involves pigment cells ([@bib5]). Several observations indicate that BalaT functions in retina pigment cells to help regenerate histamine. Most notably, BalaT is expressed in pigment cells and visual transmission is rescued in *balat* mutants by the expression of wild-type BalaT in pigment cells, but not photoreceptor neurons. Our work provides strong genetic evidence for the involvement of retinal pigment cells in histamine recycling, and suggests that BalaT is the key player responsible for the transport of β-alanine into pigment cell.

It has been suggested that the transportation of histamine metabolites within the *Drosophila* visual system is mediated by a network of retinal pigment cells and laminar glia that are interconnected by gap junctions, and that this transport network is essential for fly vision ([@bib7]). However, histaminergic photoreceptor cells directly acquire carcinine from synaptic terminals within the optic lamina through a CarT-dependent trafficking pathway ([@bib39]). Here we provided evidence that the intercellular gap junctions between retinal pigment cells and laminar glial cells are involved in trafficking β-alanine, another histamine metabolite. Although the Inx2 gap junction protein is required in laminar glial cells for visual transmission, Inx2 was not required in retinal pigment cells. In contrast, downregulating the gap junction proteins Inx1 and Inx3 within the compound eye greatly impaired photoreceptor synaptic transmission. These data indicate that the Inx1 and Inx3 proteins are required in retinal pigment cells for maintaining fly vision. It has also been suggested that gap junctions may play a role in the formation of synapses between the retina and lamina in the *Drosophila* visual system ([@bib10]). Therefore, an alternative explanation would be that Inx1 and Inx3 are required for the development of synapses between retinal and laminar neurons. Although electron microscopy studies in *Drosophila* have not revealed gap junctions between retinal pigment cells and laminar fenestrated glia, accumulation of β-alanine in the retinal layer of *inx1/inx3* double mutant flies indicates defective β-alanine trafficking.

BalaT belongs to the SLC22 family of transporters, which mediate sodium-independent transport of neurotransmitters, amino acids, and energy metabolites ([@bib18]). We provide evidence that BalaT functions specifically in pigment cells as a β-alanine transporter, as BalaT mediated β-alanine transport in vitro, and is expressed predominately in retinal pigment cells. The reduced levels and altered distribution of β-alanine in the heads of *balat* null mutant flies supports this hypothesis. β-alanine is one of the two constituents of the naturally occurring dipeptides, carnosine and carcinine, and is considered rate-limiting for their synthesis. Both carnosine and carcinine are found in the retina where they exert protective effects. This is because they function as antioxidants, scavenging toxic activated oxygen species ([@bib20]; [@bib25]). There is evidence that several members of the SLC family of proteins that can transportβ-alanine are present in the retina, including taurine transporter (Slc6a6/TauT) ([@bib19]). This suggests a conserved function for β-alanine trafficking in mammals and *Drosophila*.

Our current work, together with previous reports, provides evidence for the formulation of a more complete histamine recycling pathway, which is critical for sustaining photoreceptor synaptic transmission ([Figure 6](#fig6){ref-type="fig"}). In this pathway, carcinine is synthesized in epithelial glial cells within the optic lamina, and is transported back to photoreceptor cells via the synaptic cleft. Once in the photoreceptor cells it is hydrolyzed into histamine and β-alanine by Tan, and histamine is used as neurotransmitter. Meanwhile, β-alanine is released via an unknown mechanism, and is subsequently delivered to and stored within pigment cells by BalaT. Finally, β-alanine is transported back to epithelial glia through the network of retinal pigment cells and laminar glia for histamine inactivation and carcinine synthesis.10.7554/eLife.29146.024Figure 6.A model of the histamine recycling pathway.Histamine is initially synthesized by histidine decarboxylase (Hdc) in photoreceptor cells (PR). Upon light stimulation, PRs release histamine into the synaptic cleft. Released histamine is quickly taken up by an unknown histamine transporter into epithelial glial cells that express Ebony. In these glia, histamine is conjugated to β-alanine, which inactivates histamine and generates carcinine. Carcinine is released into the synaptic cleft and subsequently internalized, via CarT, by the PRs. After carcinine is hydrolyzed to histamine and β-alanine by Tan hydrolase in the PR, histamine is re-packaged into synaptic vesicles, whereas β-alanine is delivered to and subsequently internalized, via the BalaT transporter, by retinal pigment cells (PCs). PCs can store β-alanine or deliver β-alanine to the laminar glia cells through a gap junction network involving Inx1 and Inx3, which are expressed in PCs. In glial cells, β-alanine is conjugated to histamine, and the cycle repeats. Moreover, β-alanine can be synthesized by Black, which is an aspartate decarboxylase that is expressed together with Ebony in optic lobe glia.**DOI:** [http://dx.doi.org/10.7554/eLife.29146.024](10.7554/eLife.29146.024)

Materials and methods {#s4}
=====================

Fly stocks {#s4-1}
----------

The *pyd1; b^1^* (*su(r) r^C^; b^1^*)*, UAS-inx1^RNAi^*, *UAS-inx2^RNAi^*, and *UAS-inx3^RNAi^* flies were provided by the Bloomington *Drosophila* Stock Center. The *nos-Cas9* flies were obtained from Dr. J. Ni at Tsinghua University, Beijing, China. The *cart^1^* mutant flies were maintained in the lab of Dr. T. Wang ([@bib39]).

Generation of *balat* mutant and knock-in flies {#s4-2}
-----------------------------------------------

The *balat^1^* and *balat^2^* mutations were generated using the Cas9/sgRNA system ([@bib39]). Briefly, two pairs of guide RNAs targeting the *balat* locus were designed (sgRNA1: ATATAGTGCGCTATCTTGAG, sgRNA2: GTGTCTACGTGGGACTGAGT, sgRNA3: GAGGCCGGAACACCGGTTTT) and cloned into the *U6b-sgRNA-short* vector. The sgRNA1 and sgRNA2 plasmids were used to generate the *balat^1^* mutant flies, whereas sgRNA2 and sgRNA3 were used to generate the *balat^2^* mutant flies. The plasmids were injected into the embryos of *nos-Cas9* flies, and deletions were identified by PCR using the following primers: forward primer 5'-CGCCACCAGTTCCTGGAC-3' and reverse primer 5'-CCAGATGTAAGAGACGCAGTG-3'. The *balat-mcherry* knock-in flies were generated as shown in Figure S3. Briefly, sgDNA sequence was designed and cloned into the *U6b-sgRNA-short* vector. Two fragments from the *balat* locus (−1327 to −38 and +380 to+1660, where + 1 represents the transcription start site) were subcloned into a *pDM19-mcherry* vector such that they were separated by the *3XP3-mcherry* marker. The two plasmids were co-injected into the embryos of *nos-Cas9* flies, and mCherry-positive progeny were identified. By crossing these flies with *hs-Cre* flies, the 3XP3 promoter region was deleted. The *balat-mcherry* flies were finally confirmed by PCR using the following primers: forward primer 5'-AATTAATTAATGCGCACGAGAGGCC-3' and reverse primer 5'-TTCCACGATGGTGTAGTCCTCGTTG-3'.

Generation of plasmid constructs and transgenic flies {#s4-3}
-----------------------------------------------------

20 head-enriched potential transporters and the *balat* cDNA sequences were amplified from cDNA clones obtained from DGRC (Drosophila Genomics Resource Center, Bloomington, IN, USA). The mouse GAT3 cDNA sequences were amplified from mouse liver cDNA obtained from mRNA. Their entire CDS sequences were subcloned into the pCDNA3 vector (Invitrogen, Carlsbad, USA) for expression in HEK293T cells and PIB vector (Invitrogen, Carlsbad, USA) for expression in S2 cells. To construct *PninaE-balat*, *Ppdh-balat*, and *PGMR-balat*, the entire coding region of *balat* was amplified from cDNA clones and subcloned into the *pninaE-attB*, *ppdh-attB* and *pGMR-attB* vectors ([@bib39]). These constructs were injected into *M(vas-int.Dm) ZH-2A;M(3xP3-RFP.attP) ZH-86Fb* embryos, and transformants were identified on the basis of eye color. The *3xP3-RFP.attP* locus was removed by crossing with *P(Crey)* flies. HEK 293 T cells was obtained from ATCC (RRID:[CVCL_0063](https://scicrunch.org/resolver/CVCL_0063)) and S2 cells was obtained from Drosophila Genomics Resource Center (RRID:[CVCL_Z232](https://scicrunch.org/resolver/CVCL_Z232)), which have been tested for contamination of bacteria, yeast, mycoplasma and virus and has been characterized by isozyme and karyotype analysis.

Electroretinogram recordings {#s4-4}
----------------------------

ERGs were recorded as described ([@bib39]). Briefly, two glass microelectrodes were filled with Ringer's solution and placed on the surfaces of the compound eye and thorax (one each surface). The source light intensity was \~2000 lux, and the light color was orange (source light was filtered using a FSR-OG550 filter). ERG signals were amplified with a Warner electrometer IE-210, and recorded with a MacLab/4 s A/D converter and the clampelx 10.2 program (Warner Instruments, Hamden, USA).

β-alanine, histamine, and GABA uptake assay {#s4-5}
-------------------------------------------

Alanine, β-\[3-^3^H (N)\] (30--60 Ci/mM, American radiolabeled chemicals, Saint Louis, USA) uptake was measured as described ([@bib32]). Briefly, pcDNA3/RFP/BalaT or mock-transfected HEK293T cells were cultured in 12-well plates (BD-Falcon) and washed with 1 mL extracellular fluid (ECF) buffer consisting of 120 mM NaCl, 25 mM NaHCO~3~, 3 mM KCl,1.4 mM CaCl~2~,1.2 mM MgSO~4~, 0.4 mM K~2~HPO~4~,10 mM D-glucose, and 10 mM Hepes (pH 7.4) at 37°C. Uptake was initiated by applying 200 μL ECF buffer containing 7400 Bq \[^3^H\] β-alanine at 37°C. After 10 min, uptake was terminated by removing the solution, and cells were washed with 1 mL ice-cold ECF buffer. The cells were then solubilized in 1 N NaOH and subsequently neutralized. An aliquot was taken to measure radioactivity and protein content using a liquid scintillation counter and a DC protein assay kit (Bio-rad, USA), respectively, with bovine serum albumin as a standard. Histamine, histamine \[ring, Methylenes-3H(N)\] dihydrochloride, (10--40 Ci/mM, American radiolabeled chemicals, Saint Louis, USA), and GABA, 4-amino-n-\[2, 3-^3^H\]butyric acid (\[^3^H\]GABA, 30--60 Ci/mmol, PerkinElmer, Waltham, Massachusetts, USA) uptake assays were initiated by applying 200 μL ECF buffer containing 7400 Bq radiolabeled histamine or radiolabeled GABA. The mixture was incubated for 30 min. The continuous procedures are similar to the β-alanine transport assay.

Immunohistochemistry {#s4-6}
--------------------

Fly head sections (10 μm thick) were prepared from adults that were frozen in OCT medium (Tissue-Tek, Torrance, USA). Immunolabeling was performed on cryosections sections with rabbit anti-β-alanine (1:200, Abcam, USA; RRID:[AB_305476](https://scicrunch.org/resolver/AB_305476)), rat anti-RFP (1:200, Chromotek, Germany; RRID:[AB_2336064](https://scicrunch.org/resolver/AB_2336064)), rabbit anti-PDH (1:200; RRID:[AB_2570065](https://scicrunch.org/resolver/AB_2570065)) ([@bib37]) as primary antibodies. Cells transfected with BalaT-3XFLAG were incubated with mouse monoclonal anti-Flag M2 antibody (1:200, Sigma-Aldrich, USA; RRID:[AB_439685](https://scicrunch.org/resolver/AB_439685)) and. Goat anti-rabbit lgG conjugated to Alexa 488 (1:500, Invitrogen, USA; RRID:[AB_143165](https://scicrunch.org/resolver/AB_143165)), goat anti-rat lgG conjugated to Alexa 568 (1:500, Invitrogen, USA; RRID:[AB_2534121](https://scicrunch.org/resolver/AB_2534121)), and goat anti-mouse lgG conjugated to Alexa 647 (1:500, Jackson ImmunoResearch, USA; RRID:[AB_2535805](https://scicrunch.org/resolver/AB_2535805)) were used as secondary antibodies. Phalloidin conjugated to Alexa 650 (1:500, Thermo scientific, Germany; RRID:[AB_2532159](https://scicrunch.org/resolver/AB_2532159)) and DAPI (1:1000, Life Technologies, USA; RRID:[AB_2307445](https://scicrunch.org/resolver/AB_2307445)) was used to indicate photoreceptor cells and nucleus respectively. The images were recorded with a Nikon A1-R confocal microscope.

The phototaxis assay {#s4-7}
--------------------

Flies were dark adapted for 15 min before phototaxis assay, as described ([@bib39]). Phototaxis index was calculated by dividing the total number of flies by the number of flies that walked above the mark. At least three groups of flies were collected for each genotype and three repeats were made for each group. Each group contained ≥20 flies. Results were expressed as the mean of the mean values for the three groups.

RNA extraction and qPCR {#s4-8}
-----------------------

Total RNA was prepared from the heads of 3-day-old flies using Trizol reagent (Invitrogen, Carlsbad, USA), followed by TURBO DNA-free DNase treatment (Ambion, Austin, USA). Total cDNA was synthesized using an iScript cDNA synthesis kit (Bio-Rad Laboratories, USA). iQ SYBR green supermix was used for real-time PCR (Bio-Rad Laboratories, USA). Three different samples were collected from each genotype. The primers used for qPCR were as follows:

*ninaE-fwd*, 5'-ACCTGACCTCGTGCGGTATTG-3'

*ninaE-rev*, 5'-GGAGCGGAGGGACTTGACATT-3'

g*pdh-fwd*, 5'-GCGTCACCTGAAGATCCCATG-3'

*gpdh-rev*, 5'-CTTGCCATACTTCTTGTCCGT-3'

*pdh-fwd*, 5'-GCTTGGCGAACGAAAAGTACT-3'

*pdh-rev*, 5'-GTCACTCGTTTCCGGGAAGAT-3'

*balat-fwd,* 5'- AGACATCACACTGCTGCTCTAC -3'

*balat-rev*, 5'- CCTCCTCCAAAGTCTGTGGAAG -3'

Liquid chromatography--mass spectrometry (LC-MS) {#s4-9}
------------------------------------------------

The Dionex Ultimate 3000 UPLC system was coupled to a TSQ Quantiva Ultra triple-quadrupole mass spectrometer (Thermo Fisher, CA), equipped with a heated electrospray ionization (HESI) probe in negative ion mode. Extracts were separated by a Fusion-RP C18 column (2 × 100 mm, 2.5 μm, phenomenex). Data acquired in selected reaction monitoring (SRM) for histamine, carcinine, and β-alanine with transitions of 112/95.2, 183/95, and 90/72, respectively. Both precursor and fragment ions were collected with resolution of 0.7 FWHM. The source parameters are as follows: spray voltage: 3000 V; ion transfer tube temperature: 350°C; vaporizer temperature: 300°C; sheath gas flow rate: 40 Arb; auxiliary gas flow rate: 20 Arb; CID gas: 2.0 mTorr. Data analysis and quantification were performed using the software Xcalibur 3.0.63 (Thermo Fisher, CA). Each sample contained 50 Drosophila heads, and the mean values from five samples were calculated.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"The β-alanine transporter BalaT is required for visual neurotransmission in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Hong-Sheng Li (Reviewer \#2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that although the work is of interest, it will not be considered further for publication in *eLife* as the findings at this stage are too preliminary. However, if you can address the comments raised by the reviewers we are willing to re-review a substantially edited version that address the reviewers concern.

The following are important issues to address:

The authors proposed that β-Ala diffuses between retinal and lamina through gap junctions and provided RNAi evidence that either Inx1 or Inx3 forms the junctions. Although this hypothesis represents the most direct model of β-Ala trafficking, EM studies from both *Drosophila* and Musca didn\'t reveal any gap junction between retinal pigment cells and laminar fenestrated glia.

We know from research reported from the Hovemann lab that epithelial glia express Black, which synthesizes β-alanine from aspartate (Ziegler 2013, J Comp Neurol 521: 1207-1224). In the same paper the coexpression of Ebony in the epithelial glia was also demonstrated. This indicates that the machinery to produce β-alanine and carcinine is exactly present in the site involved in β-alanyl-histamine synthesis and probably should be sufficient to maintain the histamine recycling. It is strange that the authors choose not to report the findings of that study, since they bear critically on this submission.

The authors\' interests seem to be one-sided and focus only on β-alanine transport, as shown in [Figure 1A](#fig1){ref-type="fig"}. As a standard in [Figure 1B](#fig1){ref-type="fig"} is presented the function of a transporter that is not specific for β-alanine transport e.g. GAT3. In [Figure 1B](#fig1){ref-type="fig"} the tritiated β-alanine uptake into S2 cells is similar for that for CG3790 and for the GABA transporter GAT3. Why have the authors not checked whether CG3790 is a GABA transporter in *Drosophila*? Maybe CG3790 also acts as a transporter for other biologically important and structurally similar molecules, such as glycine, taurine or even glutamate. Transport by the product of CG3790 of some other substances engaged in phototransmission, could explain the ERG abnormalities observed after deleting this gene. Why did the authors not test histamine as a substrate for CG3790 product?

Reviewer \#1:

Wang et al. present a straightforward manuscript on the characterization of a novel β-alanine transporter with a specific defect in visual transmission in *Drosophila*. This is an interesting system to study neurotransmitter recycling through support cells, even though the neurotransmitter system itself (histamine) is quite special. The manuscript presents the novel and interesting finding, namely that in addition to glia cells another cell type, the interommatidial pigment cells, have a special requirement in the process: histamine is generated through \'splitting\' of histamine and β-alanine from carcinine in photoreceptor terminals; β-alanine is apparently then taken up by the pigment cells through the newly described BalaT transporter for delivery into glia cells, where histamine and β-alanine get conjugated again for delivery back into photoreceptor terminals.

The strength of the manuscript is in the clear straight-forward discovery of the balat transporter using a β-alanine uptake assay and demonstration of its function in pigment cells using cell-specific rescue. The link to glia is a bit weaker: RNAi experiments in two innexins that are supposed to be the delivery route of β-alanine back into the glia are not controlled and not fully convincing. This and a few minor gaps in the story can be fixed in a reasonable amount of time. These fixes should include a better characterization of the *balat-mcherry*, quantification of ERGs and better immunohistochemistry.

The key experiment I would like to see regards the innexin link: if innexin mutants really are the link between pigments cells and glia, then β-alanine should accumulate in the pigment cells in the innexin double RNAi knock-down (which also needs some RNAi controls). With inclusion of these revisions, I am in support of the manuscript.

Reviewer \#2:

The *Drosophila* visual system is a great model in the study of neurotransmitter homeostasis, in which the primary visual transmitter, histamine, is recycled through a glial pathway that involves two essential enzymes (Ebony and Tan) and multiple steps of transmembrane transport. Previous genetic and immunostaining data have suggested the involvement of retinal pigment cells in the storage/transport of β-Ala, a histamine-inactivating metabolite during this transmitter recycling. Here Wang et al. identified a β-Ala transporter in the pigment cells and demonstrated its importance to the visual transmission at both electrophysiological and behavioral levels. This is merely the second membrane transporter identified in the histamine recycling pathway, and the work provides direct evidence for the involvement of retinal pigment cells.

My only concern is about the step of β-Ala transport from pigment cells to laminal glia, where β-Ala is conjugated to histamine to form the inactive metabolite carcinine. The authors proposed that β-Ala diffuses between retinal and lamina through gap junctions and provided RNAi evidence that either Inx1 or Inx3 forms the junctions. Although this hypothesis represents the most direct model of β-Ala trafficking, EM studies from both *Drosophila* and Musca didn\'t reveal any gap junction between retinal pigment cells and laminar fenestrated glia. It is thus important to discuss on alternative, Inx-independent trafficking mechanisms. The ERG defects of Inx1+Inx3 knockdown flies could have different interpretations. For instances, they could be required for the development of synapses between retinal and laminar neurons (see Curtin et al., 2002, J. Cell Sci.), or for the β-Ala transport into core cells for storage.

Reviewer \#3:

The authors report a new β-alanine transporter, encoded by CG3790, which they named BalaT, and which is present in the retinal pigment cells of the *Drosophila* visual system. The results indicate that BalaT is critical for β-alanine recycling together with the action of innexins. The authors demonstrate that lacking BalaT disrupts the normal ERG and phototaxis. The results are consistent with the authors\' theory but they run contrary to current knowledge about β-alanine and its sources in the *Drosophila* head. We know from research reported from the Hovemann lab that epithelial glia express Black, which synthesizes β-alanine from aspartate (Ziegler 2013, J Comp Neurol 521: 1207-1224). In the same paper the coexpression of Ebony in the epithelial glia was also demonstrated. This indicates that the machinery to produce β-alanine and carcinine is exactly present in the site involved in β-alanyl-histamine synthesis and probably should be sufficient to maintain the histamine recycling. It is strange that the authors choose not to report the findings of that study, since they bear critically on this submission. What do the authors suppose is the reason that the long way to transport β-alanine into the epithelial glia, as suggested in their manuscript, would offer adaptive advantage and be critical for histamine recycling? It seems obvious that the more energetically demanding process should be outcompeted by the simpler one. The authors have forgotten to mention, or possibly have overlooked the Ziegler et al. (2013) paper in their manuscript, and in this way have avoided discussing the strongest arguments against their proposed β-alanine recycling pathway. From the work of others (Borycz et al. 2012, J Exp Biol 215: 1399-1411; Ziegler 2013, J Comp Neurol 521: 1207-1224; Rawls 2006, Genetics 172: 1665-1674) it is known that the metabolism of uracil produces β-alanine, so it is a substance present in all living cells. These biochemical processes are not the only ones and there are also reports of alternative pathways for β-alanine synthesis. Borycz et al. (2012) reported more than 10 ng β-alanine/head in the wild type, which is 5 times the histamine head content in these flies. The process of histamine conjugation with β-alanine, mediated by Ebony in the epithelial glia, requires roughly equal amounts of both compounds, which indicates that head β-alanine greatly exceeds the requirements for Ebony function. The abundance of β-alanine may in fact indicate that there is no need to recycle this substance. For these reasons the controversy with the Ziegler at al. (2012) paper should be resolved, and could only be considered in a resubmitted version.

The authors\' interests seem to be one-sided and focus only on β-alanine transport, as shown in [Figure 1A](#fig1){ref-type="fig"}. As a standard in [Figure 1B](#fig1){ref-type="fig"} is presented the function of a transporter that is not specific for β-alanine transport e.g. GAT3. In [Figure 1B](#fig1){ref-type="fig"} the tritiated β-alanine uptake into S2 cells is similar for that for CG3790 and for the GABA transporter GAT3. Why have the authors not checked whether CG3790 is a GABA transporter in *Drosophila*? Maybe CG3790 also acts as a transporter for other biologically important and structurally similar molecules, such as glycine, taurine or even glutamate.

Transport by the product of CG3790 of some other substances engaged in phototransmission, could explain the ERG abnormalities observed after deleting this gene. Why did the authors not test histamine as a substrate for CG3790 product? The histamine transporter has yet to be discovered and histamine is the neurotransmitter of major importance in the fly\'s visual system.

Additionally, use of human embryonic kidney cells (HEK293T) to study the invertebrate transporter function may be methodologically a wrong decision. The concentrations of some ions and molecules may be different in insect and human cells, so that the observed effect may be irrelevant to the results that could be seen in the appropriate cells/tissues.

The metabolite β-alanine is structurally similar to L-alanine or D-alanine as well as to GABA and glycine. These substances should all also be analysed when assessing the uptake ([Figure 1](#fig1){ref-type="fig"}) and also considered as a source of noise observed in immunolabeling ([Figure 5](#fig5){ref-type="fig"}).

Finally, the legends for the figures are scarce and abbreviations are often not explained, neither in the legend nor in the text. For example, to what does RFP in [Figure 1A](#fig1){ref-type="fig"} refer?

The results connected to the role of innexins are interesting and may indicate their role in balancing the neuronal voltage gradients but again their link to β-alanine may be misleading. Altogether, before it could be reconsidered, the paper requires substantial revision and addressing all important questions related to the previous β-alanine findings. The only link to β-alanine transport provided by the authors are the data shown in [Figure 1](#fig1){ref-type="fig"}, because the ERGs and phototaxis fail to differentiate between β-alanine and other factors involved in the process.

To report a protein as a transporter requires more detailed analysis of the transporter kinetics than the data shown in the manuscript.

In addition, the flies used in the study all contained a background of *w1118*, which is itself an ABC-transporter-deficient mutant, and this may be a factor adding to the final results.

In the list of references for *eLife*, the authors should be listed in alphabetical order and not chronological one. This omission suggests a lack of care in preparation of the manuscript for submission. Overall I cannot recommend this submission for publication in its present form.

10.7554/eLife.29146.026

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

Reviewer \#1:

\[...\] The strength of the manuscript is in the clear straight-forward discovery of the balat transporter using a β-alanine uptake assay and demonstration of its function in pigment cells using cell-specific rescue. The link to glia is a bit weaker: RNAi experiments in two innexins that are supposed to be the delivery route of β-alanine back into the glia are not controlled and not fully convincing. This and a few minor gaps in the story can be fixed in a reasonable amount of time. These fixes should include a better characterization of the balat-mcherry, quantification of ERGs and better immunohistochemistry.

We improved the immunostaining assays in *balat-mcherry* flies, and now show these results in [Figure 3](#fig3){ref-type="fig"}. We also quantified the ERG OFF transients (data are shown in [Figure 2D](#fig2){ref-type="fig"}).

The key experiment I would like to see regards the innexin link: if innexin mutants really are the link between pigments cells and glia, then β-alanine should accumulate in the pigment cells in the innexin double RNAi knock-down (which also needs some RNAi controls). With inclusion of these revisions, I am in support of the manuscript.

We performed the experiments as suggested. We performed β-alanine immunostaining to examine the in vivo levels of β-alanine in heads of control (knocking down of CG9962 and CG2198, which do not express in compound eyes), and Inx1/Inx3 double knockdown flies. These results have been added to [Figure 4H, 4I and 4J](#fig4){ref-type="fig"}, and described in the Results section (subsection "β-alanine levels and distributions are altered in *balat* mutant flies", last paragraph). In Inx1/Inx3 double knockdown flies, β-alanine levels were slightly increased and largely accumulated in the retinal layer compared with controls, which confirmed our hypothesis that Inx1/Inx3 functions to transport β-alanine back to glia cells.

Reviewer \#2:

\[...\] My only concern is about the step of β-Ala transport from pigment cells to laminal glia, where β-Ala is conjugated to histamine to form the inactive metabolite carcinine. The authors proposed that β-Ala diffuses between retinal and lamina through gap junctions and provided RNAi evidence that either Inx1 or Inx3 forms the junctions. Although this hypothesis represents the most direct model of β-Ala trafficking, EM studies from both Drosophila and Musca didn\'t reveal any gap junction between retinal pigment cells and laminar fenestrated glia. It is thus important to discuss on alternative, Inx-independent trafficking mechanisms. The ERG defects of Inx1+Inx3 knockdown flies could have different interpretations. For instances, they could be required for the development of synapses between retinal and laminar neurons (see Curtin et al., 2002, J. Cell Sci.), or for the β-Ala transport into core cells for storage.

We have analyzed β-alanine levels and performed β-alanine immunostaining of inx1/inx3 double knock-down mutants (data is shown in [Figure 4H, 4I and 4J](#fig4){ref-type="fig"}). Β-alanine largely accumulated in the retinal layer. This may represent direct evidence that Inx1/Inx3 functions to transport β-alanine back to glia cells. However, we have been unable to detect gap junctions between these cells at the EM level. Therefore, we discuss the possibilities that developmental roles of Inx may be an alternative explanation (Discussion, fifth paragraph).

Reviewer \#3:

The authors report a new β-alanine transporter, encoded by CG3790, which they named BalaT, and which is present in the retinal pigment cells of the Drosophila visual system. The results indicate that BalaT is critical for β-alanine recycling together with the action of innexins. The authors demonstrate that lacking BalaT disrupts the normal ERG and phototaxis. The results are consistent with the authors\' theory but they run contrary to current knowledge about β-alanine and its sources in the Drosophila head. We know from research reported from the Hovemann lab that epithelial glia express Black, which synthesizes β-alanine from aspartate (Ziegler 2013, J Comp Neurol 521: 1207-1224). In the same paper the coexpression of Ebony in the epithelial glia was also demonstrated. This indicates that the machinery to produce β-alanine and carcinine is exactly present in the site involved in β-alanyl-histamine synthesis and probably should be sufficient to maintain the histamine recycling. It is strange that the authors choose not to report the findings of that study, since they bear critically on this submission. What do the authors suppose is the reason that the long way to transport β-alanine into the epithelial glia, as suggested in their manuscript, would offer adaptive advantage and be critical for histamine recycling? It seems obvious that the more energetically demanding process should be outcompeted by the simpler one. The authors have forgotten to mention, or possibly have overlooked the Ziegler et al. (2013) paper in their manuscript, and in this way have avoided discussing the strongest arguments against their proposed β-alanine recycling pathway. From the work of others (Borycz et al. 2012, J Exp Biol 215: 1399-1411; Ziegler 2013, J Comp Neurol 521: 1207-1224; Rawls 2006, Genetics 172: 1665-1674) it is known that the metabolism of uracil produces β-alanine, so it is a substance present in all living cells. These biochemical processes are not the only ones and there are also reports of alternative pathways for β-alanine synthesis. Borycz et al. (2012) reported more than 10 ng β-alanine/head in the wild type, which is 5 times the histamine head content in these flies. The process of histamine conjugation with β-alanine, mediated by Ebony in the epithelial glia, requires roughly equal amounts of both compounds, which indicates that head β-alanine greatly exceeds the requirements for Ebony function. The abundance of β-alanine may in fact indicate that there is no need to recycle this substance. For these reasons the controversy with the Ziegler at al. (2012) paper should be resolved, and could only be considered in a resubmitted version.

It is our mistake that we did not discuss in detail the relationship between de novo synthesis and recycle of β-alanine. To remedy this, we have added two paragraphs to the Discussion (second and third paragraphs).

In wild type flies, β-alanine levels in the head are 5 times higher than histamine. Even in pyd and black double mutant flies, β-alanine levels are still higher than histamine. Black is expressed in Ebony-expressing lamina glia, and serves as the major enzyme in the local generation of β-alanine. The pyrimidine catabolism pathway is an alternative pathway for β-alanine synthesis. However, the *pyd* and *black* double mutant flies do not completely lose the ability to synthesize β-alanine, which may be due to the uptake of exogenous β-alanine. This low level of β-alanine is enough to sustain visual transduction. If β-alanine does not need to be recycled, the phenotype should be the same as seen in ebony mutants. Therefore, the normal visual response in black and *pyd,black* double mutants indicates that the β-alanine shuttle system indeed exists in the visual system. In *balat* mutant flies, levels of β-alanine in the head are reduce as well, but remain a few times higher than histamine. However, *balat* mutant flies display obvious ERG phenotypes, as they lack "on" and "off" transients. If the abundance of β-alanine indicates that there is no need to recycle this substance, we should not observe ERG phenotypes and β-alanine decreases in *balat* mutant fly heads. We could explain this by the β-alanine distribution changes which indicates that the β-alanine trafficking is blocked.

It has been demonstrated in many cases that de novo synthesis and the recycling of metabolites are both critical to maintain their threshold levels. For example, histamine is easily generated by Hdc in photoreceptor cells. However, the recycling of histamine to photoreceptor cells is also important to sustain visual transduction. Loss of either pathway disrupted visual transduction. However, loss of visual transduction caused by mutations in *Hdc* (which disrupts de novo synthesis) can be fully restored by feeding histamine. The same situation occurred in pyd and black double mutant flies, in which exogenous β-alanine is enough to keep β-alanine levels over histamine. In contrast, feeding histamine did not restore visual transduction in ebony mutants (which affect the recycle pathway). This situation is similar to balat-dependent β-alanine trafficking, which is required for synaptic transmission even though local de novo synthesis takes place in glia cells.

The authors\' interests seem to be one-sided and focus only on β-alanine transport, as shown in [Figure 1A](#fig1){ref-type="fig"}. As a standard in [Figure 1B](#fig1){ref-type="fig"} is presented the function of a transporter that is not specific for β-alanine transport e.g. GAT3. In [Figure 1B](#fig1){ref-type="fig"} the tritiated β-alanine uptake into S2 cells is similar for that for CG3790 and for the GABA transporter GAT3. Why have the authors not checked whether CG3790 is a GABA transporter in Drosophila? Maybe CG3790 also acts as a transporter for other biologically important and structurally similar molecules, such as glycine, taurine or even glutamate.

We have assessed the transporter specificity of CG3790. CG3790 did not transport Histamine or GABA. We have added these data to figures ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) and to the Results section (subsection "CG3790 transports β-alanine in vitro", second paragraph).

Transport by the product of CG3790 of some other substances engaged in phototransmission, could explain the ERG abnormalities observed after deleting this gene. Why did the authors not test histamine as a substrate for CG3790 product? The histamine transporter has yet to be discovered and histamine is the neurotransmitter of major importance in the fly\'s visual system.

We preformed histamine uptake assays, which revealed that CG3790 does not exhibit histamine uptake activity. As a control, the human Organic Cation Transporter (OCT2), which is known to take up histamine, exhibited high levels of histamine transport activity ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and Results subsection "CG3790 transports β-alanine in vitro", second paragraph").

Additionally, use of human embryonic kidney cells (HEK293T) to study the invertebrate transporter function may be methodologically a wrong decision. The concentrations of some ions and molecules may be different in insect and human cells, so that the observed effect may be irrelevant to the results that could be seen in the appropriate cells/tissues.

For ease of manipulation we used HEK293T cells to screen for putative fly β-alanine transporters. We then performed all CG3790 transport experiments in S2 cells ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

The metabolite β-alanine is structurally similar to L-alanine or D-alanine as well as to GABA and glycine. These substances should all also be analysed when assessing the uptake ([Figure 1](#fig1){ref-type="fig"}) and also considered as a source of noise observed in immunolabeling ([Figure 5](#fig5){ref-type="fig"}).

We asked whether CG3790 is able to transport GABA. In contrast to mGAT3, which exhibited high levels of GABA transporting activity, CG3790 did not show any GABA transporting activity when expressed in S2 cells (subsection "CG3790 transports β-alanine in vitro", second paragraph).

Finally, the legends for the figures are scarce and abbreviations are often not explained, neither in the legend nor in the text. For example, to what does RFP in [Figure 1A](#fig1){ref-type="fig"} refer?

We have reviewed the figure legends and fixed the abbreviations. For example, we have changed "RFP" to "red fluorescent protein (RFP)" as a negative control in [Figure 1](#fig1){ref-type="fig"} figure legend.

The results connected to the role of innexins are interesting and may indicate their role in balancing the neuronal voltage gradients but again their link to β-alanine may be misleading. Altogether, before it could be reconsidered, the paper requires substantial revision and addressing all important questions related to the previous β-alanine findings. The only link to β-alanine transport provided by the authors are the data shown in [Figure 1](#fig1){ref-type="fig"}, because the ERGs and phototaxis fail to differentiate between β-alanine and other factors involved in the process.

We performed β-alanine immunostaining to examine the in vivo levels of β-alanine in heads of Inx1/Inx3 double knockdown flies. These results have been added to [Figure 4H, 4I and 4J](#fig4){ref-type="fig"}, and described in the Results section (subsection "β-alanine levels and distributions are altered in *balat* mutant flies", last paragraph"). In Inx1/Inx3 double knockdown flies, β-alanine levels were slightly increased and largely accumulated in the retinal layer compared with controls, which confirmed our hypothesis that Inx1/Inx3 functions to transport β-alanine back to glia cells.

To report a protein as a transporter requires more detailed analysis of the transporter kinetics than the data shown in the manuscript.

We have strong evidence to show that Balat is specific β-alanine transporter. Although kinetic data would be a nice addition to the manuscript, we do not think these data would dramatically improve the manuscript.

In addition, the flies used in the study all contained a background of w1118, which is itself an ABC-transporter-deficient mutant, and this may be a factor adding to the final results.

To rule out the influence of the *white* gene, we crossed the *balat* mutation into the *w^+^* background. The "on" and "off" transients were still absent. We have added these data to [Figure 2C and 2D](#fig2){ref-type="fig"}, and to the Results section (subsection "BalaT is required for visual synaptic transmission", second paragraph).

In the list of references for eLife, the authors should be listed in alphabetical order and not chronological one. This omission suggests a lack of care in preparation of the manuscript for submission. Overall I cannot recommend this submission for publication in its present form.

We have listed the references in alphabetical order.

[^1]: These authors contributed equally to this work.
